The Life Sciences & Healthcare team offers you a broad range of expertise in the pharmaceutical, medical and biotechnology field combined with long-term extensive IP experience which includes advising innovative pharmaceutical and medical device companies. Our team also has an enviable track record of success representing clients at opposition and appeal hearings before the EPO.

The team has a wealth of experience in managing global patent portfolios experience in the following areas: small molecule drugs, dosage regimes, new chemical entities, peptide and antibody therapeutics, pharmaceutical formulations, supplementary protection certificates (SPCs) and medical devices.

Read more

Meet the team

Below are the key members of the Life Sciences & Healthcare team.

Isobel Finnie

UK and European Patent Attorney

Isobel is a Partner in our Life Sciences & Healthcare team who is highly regarded for using a collaborative and pragmatic approach to develop and implement IP strategies to support commercial requirements of SMEs in the life sciences and healthcare sectors. She has counselled clients from spin-out, though asset acquisition and IPO.

Her multi-disciplinary practice embraces a wide variety of life science technologies, especially in the fields of biotechnology and biochemistry. In the healthcare space she has developed considerable technical and professional expertise in the fields of cancer therapeutics and cancer pro-drugs, dermatology, biomarkers, diagnostics and companion diagnostics, vaccines, diabetes therapeutics, immunology, antibody-based therapeutics, stem cell technologies, DNA sequencing technologies and medical devices.

Joseph Lenthall

UK and European Patent Attorney

Joe is a Partner in our Life Sciences and Healthcare team with particular expertise in complex multi-party EPO Oppositions and Appeals. Recent cases include defending patents relating to antibody-drug conjugates, protein kinase inhibitors, thin film drug delivery and companion diagnostics.

His extensive experience of EPO validity challenges feeds back into his drafting, prosecution and patent management practice to ensure that he provides robust strategic advice for his clients. Joe frequently works closely with in-house counsel to deliver outcomes aligned with the client’s business needs.

Sandeep Basra

German and European Patent Attorney

Sandeep is a Partner in our Life Sciences & Healthcare team and is a German and European Patent Attorney. Having spent many years in research, Sandeep is an inventor on patent applications related to small molecule synthesis. This experience has served her well when working directly with inventors to capture their invention in the most effective way.

A majority of her current work focuses on patent drafting and prosecution, opposition and infringement matters concerning German and European patents in the area of pharmaceuticals, particularly concerning small molecules, novel formulations and second medical uses. Sandeep also advises clients on SPC matters.

David Hammond

UK and European Patent Attorney

David is a partner in our Life Sciences & Healthcare team and, with degrees in both chemistry and DNA technology, is one of our go-to attorneys for innovations in the pharma and biotech areas. He advises multi-nationals, universities, start-ups and SMEs on contentious and non-contentious issues to shape their IP strategies, giving clear, commercially-focussed advice and managing global portfolios directed to biomarker diagnostics, surgical devices, small molecule therapeutics for treating ocular diseases, cancer and neuropathic and neurodegenerative disorders, combination therapies, nucleic acid technologies and acne treatments.

Joanna Deas

UK and European Patent Attorney

Joanna is a Partner in our Life Sciences & Healthcare team and has experience working with several of the top pharmaceutical and medical device companies.  Not only does she have experience handling global IP portfolios, she also has a proven track-record handling many opposition and appeal cases before the EPO including high value business critical cases for Novo Nordisk, Baxter Healthcare and Edwards Lifesciences. She is a keen advocate of setting up mock opposition and appeal hearings to trial run and stress-test cases.

Insights from our team

Other specialist teams